Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Optimizer II seeks a niche in weaponry against heart failure

    The armamentarium of devices to shock and assist the pumping action of the heart seems to have grown rather full, with seemingly little room for new ones. Pacemakers, defibrillators, ventricular assist devices and even the artificial heart have provided an increasing range of technologies for supporting and retaining important functions and even substituting for the heart.
  • Full December 1, 2003 Issue in PDF

  • Product Pipeline

    In what constitutes a new phase in the development of its technology for the heart assist market, Thoratec (Pleasanton, California) last month reported the start of its Phase I safety trial for its HeartMate II axial-flow left ventricular assist device.
  • Personnel File

    CardioGenesis (Foothill Ranch, California) reported that Chairman and Chief Executive Officer Michael Quinn has resumed the position of president, effective immediately, replacing Darrell Eckstein, who left the company to pursue other interests.
  • Market Updates

    Physical examinations can provide critical information unavailable by other means to help patients experiencing urgent cardiac care issues, such as heart attack or unstable chest pain, according to research conducted at the Cleveland Clinic (Cleveland, Ohio).
  • Agreements

    GE Medical Systems (Waukesha, Wisconsin) and Guidant (Indianapolis, Indiana) have entered into a long-term relationship to advance and improve patient care.
  • Business Developments

    In the wake of late-October reports of adverse events with Cordis (Miami Lakes, Florida) Cypher drug-eluting stent, the Johnson & Johnson (New Brunswick, New Jersey) unit sponsored a webcast in early December that included prominent interventional cardiologists as well as a top executive from the company.
  • New TMR data from PLC, CardioGenesis

    The frenzied pace of discovery in the cardiovascular sector was reflected at the American Heart Associations (AHA; Dallas, Texas) annual scientific sessions with a flurry of significant new data presented at the cavernous Orange County Convention Center during the November meeting.
  • Cell therapies and less-invasive technologies highlighted at AHA

    The 2003 meeting of the American Heart Association (AHA, Dallas, Texas), held here in early November, provided a window on the most recent developments in the diagnosis and treatment of heart disease, and on key new technologies that are expected to drive market trends in the future.
  • Trauma Reports Supplement - Delayed or Missed Diagnoses: Avoiding these Pitfalls in the Trauma Patient

    Emergency department physicians must be vigilant to accurately assess, rapidly stabilize, and appropriately transport a severely injured patient to the level of trauma care the patient requires. Instead of viewing missed injuries as occurrences that result from inexperience or incompetence, strategies to minimize the occurrence of missed injuries and the resulting consequences are needed. All aspects of a trauma system must work together to improve patient care.